-
Subject Areas on Research
-
A computational method to classify variants of uncertain significance using functional assay data with application to BRCA1.
-
A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.
-
An inevitable dilemma: prenatal testing for mutations in the BRCA1 breast-ovarian cancer susceptibility gene.
-
Assessment of small in-frame indels and C-terminal nonsense variants of BRCA1 using a validated functional assay.
-
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer.
-
Association between cytosolic expression of BRCA1 and metastatic risk in breast cancer.
-
BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelines.
-
BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer.
-
BRCA1 expression is not directly responsive to estrogen.
-
BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas.
-
BRCA1 is required for common-fragile-site stability via its G2/M checkpoint function.
-
BRCA1 mutations in primary breast and ovarian carcinomas.
-
Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today.
-
Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype-Phenotype Features-An Entity With an Increasing Incidence?
-
Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations.
-
CRISPR/Cas9-Mediated BRCA1 Knockdown Adipose Stem Cells Promote Breast Cancer Progression.
-
Cell cycle control of BRCA2.
-
Charting the landscape of tandem BRCT domain-mediated protein interactions.
-
Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer.
-
Common variation in the BRCA1 gene and prostate cancer risk.
-
Comparing Coordinated Versus Sequential Salpingo-Oophorectomy for BRCA1 and BRCA2 Mutation Carriers With Breast Cancer.
-
Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models.
-
Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition.
-
Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian Cancer.
-
Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer.
-
Cost-effectiveness of BRCA1 and BRCA2 mutation testing to target PARP inhibitor use in platinum-sensitive recurrent ovarian cancer.
-
Detection of BRCA1 mutations in women with early-onset ovarian cancer by use of the protein truncation test.
-
Development of human protein reference database as an initial platform for approaching systems biology in humans.
-
Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer.
-
Estimating the number of potential family members eligible for BRCA1 and BRCA2 mutation testing in a "Traceback" approach.
-
Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis.
-
Facilitated cascade testing (FaCT): a randomized controlled trial.
-
Genetic/familial high-risk assessment: breast and ovarian.
-
Germline Genetic Testing: What the Breast Surgeon Needs to Know.
-
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.
-
Human ovarian cancer of the surface epithelium.
-
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
-
Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers.
-
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.
-
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
-
Impact of Patents and Licensing Practices on Access to Genetic Testing for Inherited Susceptibility to Cancer: Comparing Breast and Ovarian Cancers to Colon Cancers
-
Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation.
-
Improving indel detection specificity of the Ion Torrent PGM benchtop sequencer.
-
Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance.
-
Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation.
-
Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage.
-
Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair.
-
Localization of the VHR phosphatase gene and its analysis as a candidate for BRCA1.
-
Low levels of BRCA1 protein expression predict a worse prognosis in stage I-II colon cancer.
-
Managing hereditary ovarian cancer risk.
-
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.
-
Olaparib in Patients With Metastatic Prostate Cancer With BRCA1/2 Mutation: Results From the TAPUR Study.
-
Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis.
-
Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in BRCA1 and BRCA2.
-
PARP inhibitors for chemoprevention--letter.
-
Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ.
-
Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway.
-
Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation.
-
Pilot study of rapid MR pancreas screening for patients with BRCA mutation.
-
Pioneering geneticist Mary-Claire King receives the 2014 Lasker~Koshland Special Achievement Award in Medical Science.
-
Posttraumatic stress associated with cancer history and BRCA1/2 genetic testing.
-
Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort.
-
Probing structure-function relationships in missense variants in the carboxy-terminal region of BRCA1.
-
Real-world treatment patterns of maintenance therapy in platinum-sensitive recurrent ovarian cancer.
-
Refining the role of BRCA1 in combating oxidative stress.
-
Regulation of BRCA1 phosphorylation by interaction with protein phosphatase 1alpha.
-
Repair versus Checkpoint Functions of BRCA1 Are Differentially Regulated by Site of Chromatin Binding.
-
Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer.
-
Risk factors for ovarian cancers with and without microsatellite instability.
-
Screening for the breast cancer gene (BRCA1) using a biochip system and molecular beacon probes immobilized on solid surfaces.
-
Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer.
-
Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks.
-
Surface-enhanced Raman scattering substrate based on a self-assembled monolayer for use in gene diagnostics.
-
Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer.
-
Systematic Analysis of Splice-Site-Creating Mutations in Cancer.
-
THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair Inhibitors.
-
Targeted BRCA1/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort study.
-
The genetic attributable risk of breast and ovarian cancer.
-
Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016.
-
Two identical triplet sisters carrying a germline BRCA1 gene mutation acquire very similar breast cancer somatic mutations at multiple other sites throughout the genome.
-
Yeast screens identify the RNA polymerase II CTD and SPT5 as relevant targets of BRCA1 interaction.
-
Keywords of People